Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 20];7(6):s295. Available from: https://skin.dermsquared.com/skin/article/view/2381